Ranbaxy wins 2 Lipitor patent cases in Norway

Published on Wed, Aug 30, 2006 at 09:10 |  Source : Moneycontrol.com

Updated at Wed, Aug 30, 2006 at 20:20  

6563 Investors following Pfizer. Share this News with them.
0
0
Share on Tumblr

Excerpts from Power Breakfast on CNBC-TV18 Watch the full show ยป

ALSO READ

Other Stocks in this news

Ranbaxy Laboratories |

Sources suggest that Ranbaxy has won two Lipitor patent cases in Norway. This comes after its partial win in US, reports CNBC-TV18.

The Lipitor market in Norway is pegged at USD 50 million. Ranbaxy had earlier won a Lipitor patent case in US and had lost a patent case to Pfizer .

 

  

More on Moneycontrol

Trending News

Business News

NASA turns off its last mainframe computer
Will RBI regulation prevent a gold loan bubble? "Will RBI regulation prevent a gold loan bubble?"

CNBC-TV18 Exclusive Fin Min Sources Say SUUTI Plan Will Require Cabinet Approval

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 13 2012, 17:40

Bullish on gold, but see price correction ahead: Ventura

- in Commodities

Interviews

Feb 13 2012, 19:27 | Source: CNBC-TV18

'Diverse offerings in power helping to withstand headwinds'  

Feb 13 2012, 13:33 | Source: CNBC-TV18

Vessel oversupply crashed rates, Baltic Dry Index: SCI  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com